![Cis P-tau underlies vascular contribution to cognitive impairment and dementia and can be effectively targeted by immunotherapy in mice | Science Translational Medicine Cis P-tau underlies vascular contribution to cognitive impairment and dementia and can be effectively targeted by immunotherapy in mice | Science Translational Medicine](https://www.science.org/cms/asset/4b9ea535-3327-4f4f-9d84-430f4dbda2db/aaz7615-f1.gif)
Cis P-tau underlies vascular contribution to cognitive impairment and dementia and can be effectively targeted by immunotherapy in mice | Science Translational Medicine
![P-tau subgroups in AD relate to distinct amyloid production and synaptic integrity profiles | Alzheimer's Research & Therapy | Full Text P-tau subgroups in AD relate to distinct amyloid production and synaptic integrity profiles | Alzheimer's Research & Therapy | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13195-022-01038-z/MediaObjects/13195_2022_1038_Fig1_HTML.png)
P-tau subgroups in AD relate to distinct amyloid production and synaptic integrity profiles | Alzheimer's Research & Therapy | Full Text
![Disrupted ubiquitin proteasome system underlying tau accumulation in Alzheimer's disease - ScienceDirect Disrupted ubiquitin proteasome system underlying tau accumulation in Alzheimer's disease - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0197458020303973-fx1.jpg)
Disrupted ubiquitin proteasome system underlying tau accumulation in Alzheimer's disease - ScienceDirect
Fluorescence Lifetime Imaging of p-tau Protein in Single Neuron with a Highly Selective Fluorescent Probe | Analytical Chemistry
![Phosphorylated Tau T181 ELISA Kit Wako・298-81701[Detail Information] | [Life Science]|Laboratory Chemicals-FUJIFILM Wako Chemicals U.S.A. Corporation Phosphorylated Tau T181 ELISA Kit Wako・298-81701[Detail Information] | [Life Science]|Laboratory Chemicals-FUJIFILM Wako Chemicals U.S.A. Corporation](https://labchem-wako.fujifilm.com/us/product_data/images/03666535_img02.png)
Phosphorylated Tau T181 ELISA Kit Wako・298-81701[Detail Information] | [Life Science]|Laboratory Chemicals-FUJIFILM Wako Chemicals U.S.A. Corporation
Overexpression of 14-3-3ζ Promotes Tau Phosphorylation at Ser262 and Accelerates Proteosomal Degradation of Synaptophysin in Rat Primary Hippocampal Neurons | PLOS ONE
Removal of noises using Tau-P transformation - an indigenous tool for noise attenuation in shallow seismic data
![Amyloid-associated increases in soluble tau is a key driver in accumulation of tau aggregates and cognitive decline in early Alzheimer | medRxiv Amyloid-associated increases in soluble tau is a key driver in accumulation of tau aggregates and cognitive decline in early Alzheimer | medRxiv](https://www.medrxiv.org/content/medrxiv/early/2022/01/08/2022.01.07.22268767/F6.large.jpg)
Amyloid-associated increases in soluble tau is a key driver in accumulation of tau aggregates and cognitive decline in early Alzheimer | medRxiv
![Don't Phos Over Tau”: recent developments in clinical biomarkers and therapies targeting tau phosphorylation in Alzheimer's disease and other tauopathies | Molecular Neurodegeneration | Full Text Don't Phos Over Tau”: recent developments in clinical biomarkers and therapies targeting tau phosphorylation in Alzheimer's disease and other tauopathies | Molecular Neurodegeneration | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13024-021-00460-5/MediaObjects/13024_2021_460_Fig3_HTML.png)
Don't Phos Over Tau”: recent developments in clinical biomarkers and therapies targeting tau phosphorylation in Alzheimer's disease and other tauopathies | Molecular Neurodegeneration | Full Text
Synergistic Association between Plasma Aβ1–42 and p-tau in Alzheimer's Disease but Not in Parkinson's Disease or Frontotemporal Dementia | ACS Chemical Neuroscience
![Novel tau biomarkers phosphorylated at T181, T217 or T231 rise in the initial stages of the preclinical Alzheimer's continuum when only subtle changes in Aβ pathology are detected | EMBO Molecular Medicine Novel tau biomarkers phosphorylated at T181, T217 or T231 rise in the initial stages of the preclinical Alzheimer's continuum when only subtle changes in Aβ pathology are detected | EMBO Molecular Medicine](https://www.embopress.org/cms/asset/771daae5-018f-4cc2-86b2-d0778852d928/emmm202012921-fig-0002-m.jpg)
Novel tau biomarkers phosphorylated at T181, T217 or T231 rise in the initial stages of the preclinical Alzheimer's continuum when only subtle changes in Aβ pathology are detected | EMBO Molecular Medicine
![Levels of phospho-tau (P-tau; antibodies AT8 and PHF13) and total tau... | Download Scientific Diagram Levels of phospho-tau (P-tau; antibodies AT8 and PHF13) and total tau... | Download Scientific Diagram](https://www.researchgate.net/publication/255959938/figure/fig1/AS:213415822925825@1427893705099/Levels-of-phospho-tau-P-tau-antibodies-AT8-and-PHF13-and-total-tau-were-calculated-in.png)